Pharmaceutical composition for diminishing traumatic inflammation

A composition and drug technology, applied in the field of medicine, can solve the problems of small curative effect, long course of disease, difficulty in screening antibiotics for traumatic infection, etc., and achieve remarkable effect.

Inactive Publication Date: 2015-04-29
王代玲
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, with the widespread use of antibiotics, drug-resistant strains have gradually increased. Traumatic infections are sometimes not caused by a single bacteria. Therefore, it is difficult to screen out effective antibiotics for traumatic infections, resulting in less effective curative effect and a longer course of disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0016] Select 80 cases of trauma patients, including 54 males and 26 females, aged 12-50 years, with an average of 35 years old. There were 19 cases of hands, 22 cases of forearms, 12 cases of feet, 23 cases of thighs, and 4 cases of calves. The injury time is 1d-1 month. Among them, there were 35 cases of burns and 45 cases of bruises. Symptoms are: due to ulcers, burns and other wound infections, pus or purulent secretions, or small fresh granulation growth.

[0017] Use lotion prepared in the embodiment to treat, twice a day, use 300 milliliters each time, wet compress with sterilized gauze, cover with sterilized gauze after washing. One week is a course of treatment.

[0018] Efficacy Evaluation Criteria

[0019] Healing: the wound is completely healed; effective: there is no pus and purulent secretion in the wound or the purulent secretion is significantly reduced, granulation tissue grows, and the wound is significantly reduced; invalid: after treatment, the pus and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition for diminishing traumatic inflammation. The pharmaceutical composition disclosed by the invention is prepared from the following components in parts by weight: 50-100 parts of limonium bicolour, 80-120 parts of glossogyne tenuifolia, 50-80 parts of salvia roborowskii, 50-70 parts of wallich swallowwort root, 30-60 parts of paris polyphylla, 50-80 parts of Japanese mazus herb, 30-60 parts of david's anemone, 30-50 parts of Chinese Ladiestresses Root, 40-50 parts of decaisnea fargesii, 30-60 parts of inula flower, 20-50 parts of sheargrass, 30-50 parts of sessile alternanthera herb, 40-60 parts of lithospermum, 30-50 parts of knotteflower phyla herb, and 40-60 parts of liquorice. The components in the pharmaceutical composition disclosed by the invention are interacted to have synergistic effects; the pharmaceutical composition has the obvious effect for diminishing traumatic inflammation; and thus, the pharmaceutical composition is worthy of being clinically popularized.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating trauma and reducing inflammation. Background technique [0002] Trauma infection is relatively common in clinical practice, and Western medicine treatment methods are mostly used, including local debridement and application of antibiotics. In recent years, with the widespread use of antibiotics, drug-resistant strains have gradually increased. Traumatic infections are sometimes not caused by a single bacteria. Therefore, it is difficult to screen out effective antibiotics for traumatic infections, resulting in less effective curative effect and a longer course of disease. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating wounds and reducing inflammation. [0004] In order to achieve the purpose of the present invention, the present invention provides a pharmaceutical c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P17/02A61P29/00
CPCA61K36/185A61K9/0014A61K36/27A61K36/28A61K36/30A61K36/484A61K36/53A61K36/537A61K36/71A61K36/80A61K36/85A61K36/898
Inventor 王代玲王栋
Owner 王代玲
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products